Jianling Xie
Cited by
Cited by
Cellular signalling of the receptor for advanced glycation end products (RAGE)
J Xie, JD Méndez, V Méndez-Valenzuela, MM Aguilar-Hernández
Cellular signalling 25 (11), 2185-2197, 2013
mTOR inhibitors in cancer therapy
J Xie, X Wang, CG Proud
F1000Research 5, 2078, 2016
Trends in advanced glycation end products research in diabetes mellitus and its complications
JD Méndez, J Xie, M Aguilar-Hernández, V Méndez-Valenzuela
Molecular and cellular biochemistry 341 (1), 33-41, 2010
Rapamycin toxicity in MIN6 cells and rat and human islets is mediated by the inhibition of mTOR complex 2 (mTORC2)
AD Barlow, J Xie, CE Moore, SC Campbell, JAM Shaw, ML Nicholson, ...
Diabetologia 55 (5), 1355-1365, 2012
Eukaryotic elongation factor 2 kinase activity is controlled by multiple inputs from oncogenic signaling
X Wang, S Regufe da Mota, R Liu, CE Moore, J Xie, F Lanucara, ...
Molecular and cellular biology 34 (22), 4088-4103, 2014
The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes
J Xie, TP Herbert
Cellular and Molecular Life Sciences 69 (8), 1289-1304, 2012
The MAP kinase-interacting kinases regulate cell migration, vimentin expression and eIF4E/CYFIP1 binding.
JE Beggs, S Tian, GG Jones, J Xie, V Iadevaia, V Jenei, G Thomas, ...
Biochemical Journal, 2015
cAMP inhibits mammalian target of rapamycin complex-1 and-2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity
J Xie, GA Ponuwei, CE Moore, GB Willars, AR Tee, TP Herbert
Cellular signalling 23 (12), 1927-1935, 2011
Signaling crosstalk between the mTOR complexes
J Xie, CG Proud
Translation 2 (1), e28174, 2014
Crosstalk between mTOR complexes
J Xie, CG Proud
Nature cell biology 15 (11), 1263-1265, 2013
Identification of cAMP-dependent kinase as a third in vivo ribosomal protein S6 kinase in pancreatic β-cells
CEJ Moore, J Xie, E Gomez, TP Herbert
Journal of molecular biology 389 (3), 480-494, 2009
Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases
JD Méndez, J Xie, M Aguilar-Hernández, V Méndez-Valenzuela
Molecular and cellular biochemistry 344 (1), 185-193, 2010
mTORC1 Plays an Important Role in Skeletal Development by Controlling pre-Osteoblast Differentiation
S Fitter, MP Matthews, SK Martin, J Xie, SS Ooi, CR Walkley, ...
Molecular and Cellular Biology 37 (7), MCB. 00668-16, 2017
Regulation of the elongation phase of protein synthesis enhances translation accuracy and modulates lifespan
J Xie, V de Souza Alves, T von der Haar, L O’Keefe, RV Lenchine, ...
Current Biology 29 (5), 737-749. e5, 2019
mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells
L Jossé, J Xie, CG Proud, CM Smales
Biochemical Journal 473 (24), 4651-4664, 2016
Eukaryotic elongation factor 2 kinase (eEF2K) in cancer
X Wang, J Xie, CG Proud
Cancers 9 (12), 162, 2017
Molecular mechanism for the control of eukaryotic elongation factor 2 kinase by pH: role in cancer cell survival
J Xie, H Mikolajek, CR Pigott, KJ Hooper, T Mellows, CE Moore, ...
Molecular and cellular biology 35 (10), 1805-1824, 2015
Cambogin induces caspase-independent apoptosis through the ROS/JNK pathway and epigenetic regulation in breast cancer cells.
K Shen, J Xie, H Wang, H Zhang, M Yu, F Lu, H Tan, H Xu
Molecular Cancer Therapeutics 14 (7), 1738-1749, 2015
Elongation factor 2 kinase promotes cell survival by inhibiting protein synthesis without inducing autophagy
CEJ Moore, X Wang, J Xie, J Pickford, J Barron, SR da Mota, M Versele, ...
Cellular signalling 28 (4), 284-293, 2016
Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRAS G13D mutation
T Charitou, S Srihari, MA Lynn, MA Jarboui, E Fasterius, M Moldovan, ...
British journal of cancer 121 (1), 37-50, 2019
The system can't perform the operation now. Try again later.
Articles 1–20